EP 1981842 A2 20081022 - SULFONAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC APPLICATION THEREOF
Title (en)
SULFONAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC APPLICATION THEREOF
Title (de)
SULFONAMIDDERIVATE, IHRE HERSTELLUNG UND IHRE THERAPEUTISCHE VERWENDUNG
Title (fr)
DERIVES DE SULFONAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
Publication
Application
Priority
- FR 2007000182 W 20070201
- FR 0600955 A 20060202
Abstract (en)
[origin: WO2007088276A2] The invention concerns sulfonamide derivatives of general formula (I), wherein: Ar<SUB>1</SUB> represents an aryl optionally substituted by one or several groups, an optionally substituted heterocyclyl group; T represents a -(CH<SUB>2</SUB>)<SUB>n</SUB> or a group (A); Ar<SUB>2</SUB> represents an aryl optionally substituted by one or several groups, an optionally substituted heterocyclyl group; Ar<SUB>3</SUB> represents an aryl optionally substituted by one or several groups, an optionally substituted heterocyclyl; R represents a hydrogen or a (C<SUB>1</SUB>-C<SUB>4</SUB>) alkyl; R' represents an optionally substituted (C<SUB>1</SUB>-C<SUB>4</SUB>) alkyl; a carboxylic acid, a (C<SUB>1</SUB>-C<SUB>4</SUB>) carboxylate, an optionally substituted carboxamide; in base, acid addition salt, hydrate or solvate form, or in enantiomeric, diastereoisomeric, rotameric, atropoisomeric forms or mixtures thereof. The invention also concerns the preparation method as well as the therapeutic use of the compounds of formula (I).
IPC 8 full level
C07D 295/13 (2006.01); A61K 31/18 (2006.01); C07C 311/21 (2006.01); C07C 311/29 (2006.01)
CPC (source: EP US)
A61P 1/04 (2017.12 - EP); A61P 1/12 (2017.12 - EP); A61P 1/14 (2017.12 - EP); A61P 3/00 (2017.12 - EP); A61P 3/04 (2017.12 - EP); A61P 3/06 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 5/14 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 13/02 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 21/04 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/14 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/20 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 29/02 (2017.12 - EP); C07C 311/29 (2013.01 - EP US); C07D 295/13 (2013.01 - EP US); C07B 2200/07 (2013.01 - EP US)
Citation (search report)
See references of WO 2007088276A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
FR 2896799 A1 20070803; FR 2896799 B1 20080328; EP 1981842 A2 20081022; JP 2009525312 A 20090709; US 2009054439 A1 20090226; WO 2007088276 A2 20070809; WO 2007088276 A3 20071025
DOCDB simple family (application)
FR 0600955 A 20060202; EP 07730899 A 20070201; FR 2007000182 W 20070201; JP 2008552847 A 20070201; US 18348708 A 20080731